Get in touch
gene@lifeview.com
Don’t Settle For Conventional PGT
We know how hard the IVF journey is for prospective parents — we’re doing all we can to make it better. LifeView Embryo Screening and Tests reduce the risk of miscarriage and genetic disease, increasing the success of fertility treatments.
About us
LifeView PGT is proven to provide:
- Improved accuracy
- More available embryos for transfer
- Lower miscarriage rates
- Higher pregnancy rates
Unlike any other service in the world, LifeView patients also have access to Embryo Health Scores, which have been proven to reduce the risk of common diseases such as diabetes, cancer, and heart disease in your embryo.
LifeView™ PGT provides the most advanced genetic screening for the IVF embryo available. Studies comparing LifeView to conventional testing methods proved higher pregnancy rates and lower miscarriage rates.
PGT options
PGT-A
PGT-A screens embryos for aneuploidy so that you and your care team can select an embryo with the correct number of chromosomes (euploid) for transfer, increasing your chances of success and a healthy child.
PGT-A+
PGT-A+ is done in conjunction with PGT-A and indicates if the chromosome abnormality originated from the egg (maternal) or sperm (paternal). PGT-A+ requires saliva samples from the patient, partner, and/or gamete donor in addition to embryo samples.
PGT-M
Monogenic disorders are inherited conditions caused by genetic variants in a single gene. PGT-M is designed for individuals who have a higher chance of passing on these types of conditions to their children.
Embryo Health Score® Test
The LifeView Embryo Health Score test evaluates genetic variants to assess the risk of polygenic conditions like diabetes, cancer, schizophrenia, and heart disease in your future child. It also helps you and your clinician compare disease risks among embryos to decide which one to prioritize for transfer.
PGT-SR
Individuals who are carriers of balanced chromosome rearrangements have a higher chance of creating embryos with extra or missing genetic material. This can lead to fertility problems, pregnancy loss and health issues in an ongoing pregnancy. PGT-SR is designed to select embryos without such chromosome rearrangements for transfer.
M2
Biological parents are screened for a gene associated with increased miscarriage risk. Testing for the M2 haplotype is simple and only requires a saliva sample from the biological parents. If the M2 haplotype is present in any of the biological parents it is possible to screen the embryos for the genetic variant.
Empowering Information
Learn About PGT-A+
PGT-A+ is done in conjunction with PGT-A and indicates if the chromosome abnormality originated from the egg (maternal) or the sperm (paternal).
